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Volume 59, Number 1 Abstracts 271in target lesion revascularization and target vessel occlusion in patients with
diabetes and critical limb ischemia (CLI).
Summary: It is well known percutaneous treatment of calciﬁc tibial
artery disease is now possible. Efﬁcacy of PTA using conventional balloons
for treatment of tibial artery lesions has, however, been limited by 12-month
restenosis rates reported as high as 70% (Schmidt A et al, Catheter Cardio-
vasc Interv 2010;76:1047-54). For treatment of below-the-knee arteries,
however, there is increasing evidence that local delivery of paclitaxel using
drug-eluting balloons may result in a decrease in tibial artery restenosis after
angioplasty. Reductions in 3-month binary restenosis rates have been
observed with drug-eluting balloons for below-the-knee angioplasty
compared with PTA alone (Schmidt A et al, J Am Coll Cardiol 2011;
58:1105-9). In this article, the authors report a prospective randomized trial
comparing the performance of a speciﬁc drug-eluting balloon (IN.PACT
Amphirion; Medtronic, Santa Rosa, Calif) with conventional PTA in treat-
ment of de novo, long atherosclerotic lesions of tibial arteries in patients
with diabetes. The primary end point was 1-year binary restenosis. This
was a randomized, but open-label, single-center study. Inclusion criteria
were presence of diabetes mellitus, CLI, as deﬁned as Rutherford class
$4, signiﬁcant stenosis or occlusion >40 mm of at least one below-the-
knee vessel with distal runoff, and life expectancy >1 year. Angiography
or ultrasound follow-up was used to determine binary in-segment restenosis
at 1 year. Secondary end points included clinically driven target lesion revas-
cularization, major amputation, and target vessel occlusion. This was not an
intention-to-treat study. Patients were enrolled in the study only after suc-
cessful passage of the wire through the lesion. The authors enrolled 132 pa-
tients with 158 infrapopliteal atherosclerotic lesions. Mean length of the
treated segments was 129 6 83 mm in the drug-eluting balloon group
compared with 131 6 79 mm in the PTA group (P ¼ .7). As assessed by
angiography, in >90% of patients, binary restenosis occurred in 20 of 74 le-
sions (27%) in the drug-eluting balloon group and in 55 of 74 lesions (74%)
in the PTA-alone group (P < .001). Target lesion revascularization
occurred in 18% in the drug-eluting balloon group vs 43% in the PTA-alone
group (P ¼ .002). Target vessel occlusion occurred in 17% of the drug-
eluting balloon group vs 55% of the PTA-alone group (P < .001). There
was only one major amputation, which occurred in the PTA-alone group
(P ¼ .9).
Comment: This was a nonblinded device trial performed by a single
high-volume center, and no external angiography or duplex ultrasound
core laboratories adjudicated end points. Only one major amputation was
necessary in this group of 132 patients with diabetes and CLI, suggesting
that the “critical” portion of the limb ischemia may not have been as critical
as that of patients in other centers. Nevertheless, there is enough here to
encourage industry to do the responsible thing and sponsor a proper multi-
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Conclusions: There are clinical, pathologic, and outcome differences
in spontaneous dissections of the internal carotid artery vs those of the verte-
bral artery.
Summary: Spontaneous cervical artery dissection is a major cause of
stroke in younger patients. Spontaneous cervical artery dissection causes
up to 25% of all ischemic strokes in patients 15 to 49 years of age (Putaala
J et al, Stroke 2009;40:1195-203). Although constitutional and environ-
mental factors are both thought to play a role in spontaneous cervical artery
dissection, precise causes are poorly understood. Signiﬁcant differences be-
tween spontaneous internal carotid artery dissection (sICAD) and sponta-
neous vertebral artery dissection (sVAD) have been reported by the
Cervical Artery Dissection Ischemic Stroke Patients (CADISP) group (Deb-
ette S et al, Neurology 2011;77:1174-81). The current study represents the
second large analysis and comparison of sICAD and sVAD. Data were
derived from 1027 patients with cervical CAD from two stroke centers in
Switzerland and one in France. There were 668 patients with sICAD and
302 patients with sVAD. Patients with sICAD were older (46.3 6 9.6 years
vs 42.0 6 10.2 years; P < .001), more often men (62.7% vs 53.0%; P ¼
.004). Patients with sICAD were also more likely to present with tinnitus
(10.9% vs 3.4%; P < .001) and to have more severe ischemic strokes
(median National Institutes of Health Stroke Scale: 10 6 7.1 vs 5 6 5.9;
P < .001). There were more bilateral dissections among those with sVAD
(15.2% vs 7.6%; P < .001). Patients with sVAD were more likely to be
smokers (36.0% vs 28.7%; P ¼ .007), to experience “thunderclap” headache
(9.2% vs 3.6%; P ¼ .001), and to have neck pain (65.8% vs 33.5%; P <
.001). Subarachnoid hemorrhage (6.0% vs 0.6%; P < .001) and ischemic
stroke (69.5% vs 52.2%; P < .001) were also more frequent in patients
with sVAD. With multivariate analysis, differences with respect to gender
were no longer signiﬁcant, but all other variables remained signiﬁcant. In
sVAD, favorable outcome 3 months after ischemic stroke (modiﬁed Rankin
Scale, 0-2: 88.8% vs 58.4%; P < .001), recurrent transient ischemia attack
(4.8% vs 1.1%; P ¼ .001), and recurrent ischemic stroke #3 months
(2.8% vs 0.7%; P ¼ .02) were more frequent.
Comment: The data indicate there are real, although perhaps not
necessarily clinically signiﬁcant differences with respect to the individual pa-
tient, in patients with sICAD and sVAD. In fact, the authors note that the
observed differences do not provide enough evidence to propose different
treatment strategies for sVAD vs sICAD. However, there are enough differ-
ences between the two entities that future studies on spontaneous cervical
artery dissection should provide separate analyses of patients with sVAD
and sICAD.
